venBio Select Advisor »

Tourmaline Bio shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2024-09-30 $57M 2.2M 25.71
2024-06-30 $29M 2.2M 12.86
2024-03-31 $51M 2.2M 22.90
2023-12-31 $23M 868k 26.18

More positions owned by venBio Select Advisor

United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Madrigal Pharmaceuticals Common (MDGL)
Apellis Pharmaceuticals Common (APLS)
Sarepta Therapeutics Common (SRPT)
Avidity Biosciences Common (RNA)
Amicus Therapeutics Common (FOLD)
Intra-cellular Therapies Common (ITCI)
Xenon Pharmaceuticals Common (XENE)
Kymera Therapeutics Common (KYMR)
Vera Therapeutics Common (VERA)
Arrowhead Pharmaceuticals Common (ARWR)
Biomarin Pharmaceutical Common (BMRN)

View all positions for venBio Select Advisor

Top funds holding Tourmaline Bio

RA Capital Management
venBio Select Advisor
BlackRock
Blue Owl Capital Holdings
TCG Crossover Management
Vanguard Group
Jennison Associates
Qiming U.S. Ventures Management
Rtw Investments
QVT Financial
Nantahala Capital Management
Vivo Capital
Millennium Management
Geode Capital Management
Citadel Advisors

View all funds holding Tourmaline Bio